Actinium Pharmaceuticals Inc (ATNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 20,490 | 22,242 | 25,678 | 24,762 | 25,952 |
| TOTAL | $21,413 | $23,179 | $26,482 | $24,920 | $26,210 |
| Non-Current Assets | |||||
| PPE Net | 110 | 116 | 106 | 95 | 86 |
| Investments And Advances | 50 | 50 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 35 | 35 |
| TOTAL | $160 | $165 | $106 | $130 | $121 |
| Total Assets | $21,573 | $23,344 | $26,588 | $25,050 | $26,331 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,464 | 1,878 | 1,499 | 927 | 1,036 |
| Other current liabilities | 935 | 1,230 | 2,849 | 1,228 | 1,923 |
| TOTAL | $2,489 | $3,286 | $4,614 | $2,155 | $3,051 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,489 | $3,286 | $4,614 | $2,155 | $3,051 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,589 | 1,563 | 1,478 | 1,399 | 1,353 |
| Common Shares | 47 | 45 | 44 | 42 | 41 |
| Retained earnings | -123,258 | -116,633 | -112,230 | -105,690 | -101,743 |
| TOTAL | $19,084 | $20,058 | $21,974 | $22,894 | $23,280 |
| Total Liabilities And Equity | $21,573 | $23,344 | $26,588 | $25,050 | $26,330 |